Pharm Pract Manag Q. 2001;20(3):41-55; quiz 56-9. doi: 10.1177/001857870003500403.
Pharmacy practice management quarterly
J D Grabenstein
PMID: 11291518 DOI: 10.1177/001857870003500403
UNLABELLED: CREDIT: This lesson is good for 0.2 CE units, with a passing grade of 70%.
OBJECTIVES: After completing this continuing education article, the pharmacist will be able to: 1. Compare and contrast active vs. passive immunity and homologous vs. heterogenous antibodies. 2. Describe the historical development and modern manufacture of immune globulins. 3. Identify the wide range of uses and effects of modern immune globulin products. 4. Discuss the adverse effect profiles of currently available immune globulins.